Skip to main content

Table 4 LVEDV and LVESV derived from echocardiography analysis

From: Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study

 

CON (n = 25)

Group A (n = 27)

Group B (n = 26)

Group C (n = 26)

(95 % CI)

(95 % CI)

(95 % CI)

(95 % CI)

LVEDV by echocardiography, ml

 Baseline

157.7 ± 26.1

153.1 ± 27.9

151.7 ± 21.8

154.5 ± 26.7

(148.0 to 167.3)

(141.8 to 165.4)

(142.9 to 160.5)

(143.7 to 165.3)

 6 months

156.9 ± 27.2

151.2 ± 26.3

149.8 ± 23. 5

152.8 ± 24.7

(144.8 to 168.9)

(139.3 to 162.0)

(138.6 to 158.1)

(142.1 to 163.5)

  Change from baseline

−2.5 ± 14.5

−4.0 ± 11.3

−3.7 ± 12.5

−3.8 ± 15.4

(−8.9 to 3.9)

(−10.5 to 1.8)

(−9.3 to 2.7)

(−10.4 to 2.9)

 12 months

157.5 ± 27.6

149.4 ± 25.8†

148.5 ± 20.7†

150.2 ± 26.0

(145.3 to 169.7)

(137.2 to 160.5)

(137.9 to 156.2)

(138.4 to 162.1)

  Change from baseline

−3.9 ± 18.7

−7.9 ± 13.9

−6.6 ± 10.6

−7.6 ± 18.0

(−12.2 to 4.4)

(−14.3 to −0.8)

(−11.5 to −1.4)

(−15.8 to 0.6)

LVESV by echocardiography, ml

 Baseline

93.9 ± 17.3

90.8 ± 19.3

90.5 ± 18.3

97.0 ± 25.1

(88.9 to 100.9)

(83.0 to 98.6)

(83.2 to 97.9)

(86.8 to 107.1)

 6 months

90.6 ± 21.4

77.2 ± 19.0*†‡

83.2 ± 14.7

92.2 ± 21.6

(80.8 to 100.3)

(69.3 to 85.0)

(76.3 to 90.0)

(82.9 to 101.6)

  Change from baseline

−4.0 ± 10.8

−13.4 ± 10.0†‡

−10.5 ± 11.9

−5.3 ± 12.0

(−8.9 to 0.8)

(−17.6 to −9.3)

(−16.0 to −4.9)

(−10.5 to −0.2)

 12 months

89.8 ± 22.3*

71.1 ± 19.8*†‡

73.4 ± 17.1*†‡

89.1 ± 22.6*

(80.8 to 100.3)

(62.6 to 79.7)

(64.5 to 82.2)

(78.8 to 99.4)

  Change from baseline

−6.4 ± 15.9

−20.5 ± 13.3†‡

−19.6 ± 11.1†‡

−9.4 ± 16.3

(−13.3 to 0.4)

(−26.2 to −14.7)

(−25.3 to −13.9)

(−16.8 to −1.9)

  1. * p < 0.05, vs baseline; † p < 0.05, vs control; ‡ p < 0.05, vs group C. CON control group; group A bone marrow mononuclear cell (BMC) infusion within 1 day after percutaneous coronary intervention (PCI); group B BMC infusion at 3–7 days after PCI; group C BMC infusion at 7–30 days after PCI; LVEDV left ventricular end-diastolic volume; LVESV left ventricular end-systolic volume